Loan Agreement Between Baker Brothers Life Sciences, L.P., 667, L.P., 14159, L.P., and Baker Bros. Advisors LPLoan Agreement • June 1st, 2017 • Baker Bros. Advisors Lp • Services-medical laboratories • New York
For value received, Baker Bros Advisors LP (the “Management Company”) promises to pay Baker Brothers Life Sciences, L.P., 667, L.P., and 14159, L.P., (collectively “The Funds”), the amounts set forth in Schedule A below, payable on the Due Date (as defined below) with interest payable through the Due Date at a rate of 2.75% annually.
PROCEEDS AGREEMENTProceeds Agreement • June 1st, 2017 • Baker Bros. Advisors Lp • Services-medical laboratories • New York
WHEREAS, the Agent, in his capacity as a director of Genomic Health, Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 8,250 shares of the Company common stock (the “Stock”) according to the below Schedule A;
